Dendritic cells and their potential therapeutic role in haematological malignancy

Leukemia and Lymphoma

Volumn 44, Issue 10, 2003, Pages 1657-1666

  Kaminski, Edward R ^a   Goddard, R V ^a   Prentice, A G ^a  

^a DERRIFORD HOSPITAL   (United Kingdom)

Author keywords

B CLL; Dendritic cells; Haematological malignancy; T cell function

Indexed keywords

CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IDIOTYPIC ANTIBODY; IMMUNOGLOBULIN IDIOTYPE; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOPTIVE IMMUNOTHERAPY; ALLOGRAFT; ANTIGEN PRESENTATION; ANTINEOPLASTIC ACTIVITY; AUTOIMMUNE DISEASE; AUTOTRANSPLANTATION; B LYMPHOCYTE; CELL ACTIVATION; CELL ACTIVITY; CELL FUSION; CELL MANIPULATION; CELL SPECIFICITY; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CLONAL ANERGY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DISEASE SEVERITY; HELPER CELL; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN FUNCTION; REVIEW; TUMOR SUPPRESSOR GENE;

CANCER VACCINES; CLINICAL TRIALS; DENDRITIC CELLS; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOTHERAPY; T-LYMPHOCYTES;

EID: 0141870164     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819031000090219     Document Type: Review

References (100)

1. Ben-Efraim, S. (1999) "One hundred years of cancer immunotherapy: a critical appraisal", Tumor Biol. 20, 1-24.
2. Burnet, F.M. (1970) "The concept of immunological surveillance", Prog. Exp. Tumor Res. 13, 1-27 (Karger, Basel/Munchen/New York).
3. Banchereau, J. and Steinman, R.M. (1998) "Dendritic cells and the control of immunity", Nature 392, 245-252.
4. Lanzavecchia, A. (1999) "Dendritic cell maturation and generation of immune responses", Haematologica 84, 23-25.
5. Lanzavecchia, A. and Sallusto, F. (2001) "Regulation of T cell immunity by dendritic cells", Cell 106, 263-266.
6. Romani, N., Reider, D., Heuer, M., Ebner, S., Kampgen, E., Eibl, B., Niederwieser, D. and Schuler, G. (1996) "Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability", J. Immunol. Methods 196, 137-151.
7. Morse, M.A., Zhou, L.J., Tedder, T.F., Lyerly, H.K. and Smith, C. (1997) "Generation of dendritic cells in vitro from peripheral blood mononuclear cells with granulocyte-macrophage-colony-stimulating factor, interleukin-4 and tumor necrosis factor-α for use in cancer immunotherapy", Ann. Surg. 226, 6-16.
8. Young, J.W. (1999) "Dendritic cells: expansion and differentiation with hematopoietic growth factors", Curr. Opin. Hematol. 6, 135-144.
9. Van Pel, A., van der Bruggen, P., Coulie, P.G., Brichard, V.G., Lethe, B., van den Eynde, B., Uyttenhove, C., Renauld, J.C. and Boon, T. (1995) "Genes coding for tumor antigens recognised by cytolytic T lymphocytes", Immunol. Rev. 145, 229-250.
10. Avignan, D. (1999) "Dendritic cells: development, function and potential use for cancer immunotherapy", Blood Rev. 13, 51-64.
11. Reid, C.D.L. (1998) "The biology and clinical applications of dendritic cells", Transfus. Med. 8, 77-86.
12. Pawelec, G., Rees, R.C., Kiessling, R., Madrigal, A., Dodi, A., Baxevanis, C., Gambacorti-Passerini, C., Masucci, G. and Zeuthen, J. (1999) "Cells and cytokines in immunotherapy and gene therapy of cancer", Crit. Rev. Oncog. 10, 83-127.
13. Timerman, J.M. and Levy, R. (1999) "Dendritic cell vaccines for cancer immunotherapy", Annu. Rev. Med. 50, 507-529.
14. Colaco, C.A.L.S. (1999) "Why are dendritic cells central to cancer immunotherapy?", Mol. Med. Today 5, 14-17.
15. Reid, C.D.L. (2001) "Dendritic cells and immunotherapy for malignant disease", Br. J. Heamatol. 112, 874-888.
16. Trojan, A., Shultze, J.L., Witzens, M., Vonderheide, R.H., Ladetto, M., Donovan, J.W. and Gribben, J.G. (2000) "Immunoglobulin framework-derived peptides function as cytotoxic T-cell epitopes commonly expressed in B-cell maliganancies", Nat. Med. 6, 667-672.
17. Harig, S., Witzens, M., Krackhardt, A.M., Trojan, A., Barrett, P., Broderick, R., Zauls, J. and Gribben, J.G. (2001) "Induction of cytotoxic T-cell responses against immunoglobulin V region-derived peptides modified at human leukocyte antigen-A2 binding residues", Blood 98, 2999-3005.
18. Kwak, L.W., Campbell, M.J., Czerwinski, D.K., Hart, S., Miller, R.A. and Levy, R. (1992) "Induction of immune responses in patients with B-cell lymphoma against the surface immunoglobulin idiotype expressed by their tumours", N. Engl. J. Med. 327, 1209-1215.
19. Nelson, E.L., Xiobin, L., Hsu, F.J., Kwak, L.W., Levy, R., Clayberger, C. and Krensky, A.M. (1996) "Tumour-specific, cytotoxic T-lymphocyte response after idiotype vaccination for B-cell, non-Hodgkins lymphoma", Blood 88, 580-589.
20. Hsu, F.J., Caspar, C.B., Czerwinski, D., Kwak, L.W., Liles, T.M., Syrengelas, A., Taidi-Laskowski, B. and Levy, R. (1997) "Tumour-specific idiotype vaccines in the treatment of patients with B-cell lymphoma-long term results of a clinical trial", Blood 89, 3129-3135.
21. Bendandi, M., Gocke, C.D., Kobrin, C.B., Benko, F.A., Sternas, L.A., Pennington, R., Watson, T.M., Reynolds, C.W., Gause, B.L., Duffey, P.L., Jaffe, E.S., Creekmore, S.P., Longo, D.L. and Kwak, L.W. (1999) "Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma", Nat. Med. 5, 1171-1177.
22. Hsu, F.J., Benike, C., Fagnoni, F., Liles, T.M., Czerwinski, D., Taidi, B., Engleman, E.G. and Levy, R. (1996) "Vaccination of patients with B-cell lymphomas using autologous antigen-pulsed dendritic cells", Nat. Med. 2, 52-58.
23. Osterroth, F., Garbe, A., Fisch, P. and Veelken, H. (2000) "Stimulation of cytotoxic T cells against idiotype immunoglobulin of malignant lymphoma with protein-pulsed or idiotype-transduced dendritic cells", Blood 95, 1342-1349.
24. Timmerman, J.M., Czerwinski, D.K., Davis, T.A., Hsu, F.J., Benike, C., Hao, Z.M., Taidi, B., Rajapaksa, R., Caspar, C.B., Okada, C.Y., Hao, Z.M., Taisi, T.M., Engleman, E.G. and Levy, R. (2002) "Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients", Blood 99, 1517-1526.
25. Kwak, L.W., Taub, D.D., Duffey, P.L., Bensinger, W.I., Bryant, E.M., Reynolds, C.W. and Longo, D.L. (1995) "Transfer of myeloma idiotype-specific immunity from an actively immunised marrow donor", Lancet 345, 1016-1020.
26. Bergenbrant, S., Yi, Q., Osterborg, A., Bjorkholm, M., Osby, E., Mellstedt, H., lefvert, A.K. and Holm, G. (1996) "Modulation of anti-idiotypic immune response by immunization with the autologous M-component protein in multiple myeloma patients", Br. J. Haematol. 92, 840-846.
27. Osterberg, A., Yi, Q., Henriksson, L., Qing, Yi., Henriksson, L., Fagerberg, J., Bergenbrant, S., Jeddi-Tehrani, M., Ruden, U., Lefvert, A.-K., Holm, G. and Mellstedt, H. (1998) "Idiotype immunisation combined with granulocyte-macrophage colony-stimulating factor in myeloma patients induced type I, major histocompatibility complex-restricted, CD8- and CD4-specific T-cell responses", Blood 91, 2459-2466.
28. Pfeiffer, S., Gooding, R.P., Apperley, J.F., Goldschmidt, H. and Samson, D. (1997) "Dendritic cells generated from the blood of patients with multiple myeloma are phenotypically and functionally identical to those produced from healthy donors", Br. J. Haematol. 98, 973-982.
29. Wen, Y.J., Ling, M., Bailey-Wood, R. and Lim, H. (1998) "Idiotype protein-pulsed adherent peripheral blood mononuclear cell derived dendritic cells prime immune system in multiple myeloma", Clin. Cancer Res. 4, 957-962.
30. Dabadghao, S., Bergenbrant, S., Anton, D., He, W., Holm, G. and Yi, Q. (1998) "Anti-idiotype T-cell activation in multiple myeloma induced by M-component fragments presented by dendritic cells", Br. J. Haematol. 100, 647-654.
31. Cull, G., Durrant, L., Stainer, C., Haynes, A. and Russell, N. (1999) "Generation of anti-idiotype immune responses following vaccination with idiotype-protein pulsed dendritic cells in myeloma", Br. J. Haematol. 107, 648-655.
32. Lim, S.H. and Bailey-Wood, R. (1999) "Idiotype protein-pulsed dendritic cell vaccination in multiple myeloma", Int. J. Cancer 83, 215-222.
33. Titzer, S., Christensen, O., Manzke, O., Tesch, H. and Wolf, J. (2000) "Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects", Br. J. Haematol. 108, 805-816.
34. Ratta, M., Curti, A., Fogli, M., Pantucci, M., Viscomi, G., Tazzari, P., Fagnoni, F., Vescovini, R., Sansoni, P., Tura, S. and Lemoli, R.M. (2000) "Efficient presentation of tumor idiotype to autologous cells by CD83(+) dendritic cells derived from highly purified circulating CD14(+) monocytes in multiple myeloma patients", Exp. Haematol. 28, 931-940.
35. Liso, A., Stockerl-Goldstein, K.E., Auffemann-Gretzinger, S., Bnike, C.J., Reichardt, V., van Beckhoven, A., Rajapaksa, R., Engleman, E.G., Blume, K.G. and Levy, R. (2000) "Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell transplantation for multiple myeloma", Biol. Blood Marrow Transplant. 6, 621-627.
36. Wen, Y.J., Barlogie, B. and Yi, Q. (2001) "Idiotype-specific cytotoxic T lymphocytes in multiple myeloma: evidence for their capacity to lyse autologous primary tumor cells", Blood 97, 1750-1755.
37. Butch, A.W., Kelly, K.A. and Munshi, N.C. (2001) "Dendritic cells derived from multiple myeloma patients efficiently internalise different classes of myeloma protein", Exp. Haematol. 29, 85-92.
38. Wen, Y.J., Min, R., Tricot, G., Barlogie, B. and Yi, Q. (2002) "Tumor lysate-specific cytotoxic T lymphocytes in multiple myeloma: promising effector cells for immunotherapy", Blood 99, 3280-3285.
39. Yi, Q., Desikan, R., Barlogie, B. and Munshi, N. (2002) "Optimising dendritic cell-based immunotherapy in multiple myeloma", Br. J. Haematol. 117, 297-305.
40. Dhodapkar, M.V., Krasovsky, J. and Olson, K. (2002) "T cells from the tumor microenvironment of patients with progressive myeloma can generate strong, tumor-specific cytolytic responses to autologous, tumor-loaded dendritic cells", Proc. Natl Acad. Sci. USA 99, 13009-13013.
41. Choudhury, A., Gajewski, J.L., Liang, J.C., Popat, U., Claxton, D.F., Kliche, K.-O., Andreeff, M. and Champlin, R.E. (1999) "Use of leukaemic DCs for the generation of anti-leukaemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukaemia", Blood 89, 1133-1142.
42. Eibl, B., Ebner, S., Duba, C., Bock, G., Romani, N., Erdel, M., Gachter, A., Niederwiser, D. and Schuler, G. (1997) "Dendritic cells generated from blood precursors of chronic myelogenous leukemia patients carry the Philadelphia translocation and can induce a CML-specific primary cytotoxic T-cell response", Genes Chromosomes Cancer 20, 215-223.
43. Coleman, S., Throp, D., Fisher, J., Bailey-Wood, R. and Lim, S.H. (1997) "Cytokine enhancement of immunogenicity in chronic myeloid leukemia", Leukemia 11, 2055-2059.
44. Lim, S.H., Coleman, S. and Bailey-Wood, R. (1998) "In vitro cytokine-primed leukaemia cells induce in vivo T cell responsiveness in chronic myeloid leukaemia", Bone Marrow Transplant. 22, 1185-1190.
45. Nieda, M., Nicol, A., Kikuchi, A., Kashiwase, K., Taylor, K., Suzuki, K., Tadokoro, K. and Juli, T. (1998) "Dendritic cells stimulate the expansion of bcr-abl specific CD8+ T cells with cytotoxic activity against leukemic cells from patients with chronic myeloid leukemia", Blood 91, 977-983.
46. Wang, C., Al-Omar, H.M., Radvanyi, L., Banerjee, A., Bouman, D., Squire, J. and Messner, H.A. (1999) "Clonal heterogeneity of dendritic cells derived from patients with chronic myeloid leukemia and enhancement of their T-cells stimulatory activity by IFN-alpha", Exp. Hematol. 27, 1176-1184.
47. Engels, F.H., Koski, G.K., Bedrosian, I., Xu, S., Luger, S., Nowell, P.C., Cohen, P.A. and Czerniecki, B.J. (1999) "Calcium signalling induces acquisition of dendritic cell characteristics in chronic myelogenous leukaemia myeloid progenitor cells", Proc. Natl Acad. Sci. USA 96, 10332-10337.
48. Osman, Y., Takahashi, M., Zhend, Z., Koike, T., Toba, K., Lui, A., Furakawa, T., Aoki, S. and Aizawa, Y. (1999) "Generation of bcr/abl specific cytotoxic T-lymphocytes by using dendritic cells pulsed with bcr/abl (b3a2) peptide: its applicability for donor leukocyte transfusions in marrow grafted CML patients", Leukemia 13, 166-174.
49. Fujii, A., Shimizu, K., Fujimoto, K., Kiyokawa, T., Shimomura, T., Tanaguchi, O., Kinoshita, M. and Kawano, F. (1999) "Analysis of a chronic myelogenous leukemia patient vaccinated with leukemic dendritic cells following autologous peripheral blood stem cell transplantation", Jpn J. Cancer Res. 90, 1117-1129.
50. Zheng, C., Pisa, P., Stromberg, O., Blennow, E. and Hansson, M. (2000) "Generation of dendritic cells from peripheral blood of patients at different stages of chronic myeloid leukemia", Med. Oncol. 17, 270-278.
51. Muller, L., Provenzani, C., Faul, C. and Pawelec, G. (2001) "Recognition of chronic myelogenous leukaemia cells by autologous T lymphocytes primed in vitro against the patient's DCs", Br. J. Haematol. 112, 740-748.
52. Muller, L., Provenzani, C. and Pawelec, G. (2001) "Generation of chronic myelogenous leukaemia-specific T cells in cytokine-modified autologous mixed lymphocyte/tumour cell cultures", J. Immunother. 24, 482-492.
53. Sun, J.Y., Krouse, R.S., Forman, S.J., Senitzer, D., Sniecinski, I., Chatterjee, S. and Wong, K.K., Jr. (2002) "Immunogenicity of a p210(BCR-ABL) fusion domain candidate DNA vaccine targeted to dendritic cells by a recombinant adeno-associated virus vector in vitro", Cancer Res. 62, 3175-3183.
54. Farace, F., Orlanducci, F., Dietrich, P.Y., Gaudin, C., Angevin, E., Courtier, M.H., Bayle, C., Hercend, T. and Triebel, F. (1994) "T cell repertoire in patients with B chronic lymphocytic leukemia. Evidence for multiple in vivo T cell clonal expansions", J. Immunol. 153, 4281-4290.
55. Rezvany, M.R., Jeddi-Tehrani, M., Rabbani, H., Lewin, N., Avila-Carino, J., Osterberg, A., Wigzell, H. and Mellstedt, H. (2000) "Autologous T lymphocytes may specifically recognize leukaemic B cells in patients with chronic lymphocytic leukaemia", Br. J. Haematol. 111, 608-617.
56. Goddard, R.V., Prentice, A.G., Copplestone, J.A. and Kaminski, E. (2001) "Generation in vitro of B-cells chronic lymphocytic leukaemia-proliferative and specific HLA class-II restricted cytotoxic T cell responses using autologous DCs pulsed with tumour cell lysate", Clin. Exp. Immunol. 125, 16-28.
57. Vuillier, F., Maloum, K., Thomas, E.K., Jouanne, C., Dighiero, G. and Scott-Algara, D. (2001) "Functional monocyte-derived dendritic cells can be generated in chronic lymphocytic leukaemia", Br. J. Haematol. 115, 831-844.
58. Rezvany, M.R., Jeddi-Tehrani, M., Biberfeld, P., Soderlund, J., Mellstedt, H., Osterborg, A. and Rabbani, H. (2001) "Dendritic cells in patients with non-progressive B-chronic lymphocytic leukaemia have a normal functional capability but abnormal cytokine pattern", Br. J. Haematol. 115, 263-271.
59. Goddard, R.V., Prentice, A.G., Copplestone, J.A. and Kaminski, E.R. (2003) "in vitro dendritic cell-induced T cell responses to B-cell chronic lymphocytic leukaemia enhanced by IL-15 and dendritic cell-B-CLL electrofusion hybrids", Clin. Exp. Immunol. 131, 82-89.
60. Vuillier, F., Maloum, K., Thomas, E.K., Magnac, C., Dumas, G., Payelle-Brogard, B., Oppezo, P., Dighero, G. and Scott-Algara, D. (2003) "Idiotype-pulsed dendritic cells are able to induce anti-tumoral cytotoxic DC8 cells in chronic lymphocytic leukaemia", Br. J. Haematol., In press.
61. Tanaka, Y., Takahashi, T., Nieda, M., Masuda, S., Kashiwase, K., Ogawa, S., Chiba, S., Juji, T. and Hirai, H. (2000) "Generation of HLA-DRB1*1501-restricted p190 minor bcr-abl (ela2)-specific CD4+ T lymphocytes", Br. J. Haematol. 109, 435-437.
62. Pospisilova, D., Borovickova, J., Polouckova, A., Spisek, R., Hrusak, O., Stary, J. and Bartunkova, J. (2002) "Generation of functional dendritic cells for potential use in the treatment of acute lymphoblastic leukaemia", Cancer Immunol. Immunother. 51, 72-78.
63. Choudhury, A., Liang, J.C., Thomas, E.K., Flores-Romo, L., Xie, Q.S., Agusala, K., Sutaria, S., Sinha, I., Champlin, R.E. and Claxton, D.F. (1999) "Dendritic cells derived in vitro from acute myelogenous leukemia cells stimulate autologous, antileukemic T-cell responses", Blood 93, 780-786.
64. Brouwer, R.E., van der Hoorn, M., Kluin-Nelemans, H.C., van Zelderen-Bhola, S., Willemze, R. and Falkenburg, J.H. (2000) "The generation of dendritic-like cells with increased allostimulatory function from acute myeloid leukemia cells of various FAB subclasses", Hum. Immunol. 61, 565-574.
65. Woiciechowsky, A., Regn, S., Kolb, H.J. and Roskrow, M. (2001) "Leukemic dendritic cells generated in the presence of FLT3 ligand have the capacity to stimulate an autologous leukemia-specific cytotoxic T cell response from patients with acute myeloid leukemia", Leukemia 15, 245-255.
66. Harrison, B.D., Adams, J.A., Briggs, M., Brereton, M.L. and Liu Yin, J.A. (2001) "Stimulation of autologous proliferative and cytotoxic T-cell responses by "leukemic dendritic cells" derived from blast cells in acute myeloid leukaemia", Blood 97, 2764-2771.
67. Nieda, M., Nicol, A., Koezuka, Y., Kikuchi, A., Lapteva, N., Tanaka, Y., Tokunaga, K., Suzuki, K., Kayagaki, N., Yagita, H., Hirai, H. and Juji, T. (2001) "TRAIL expression by activated human CD4(+)V alpha24NKT cells induces in vitro and in vivo apoptosis of human acute myeloid leukemia cells", Blood 97, 2067-2074.
68. Brugger, W., Schneider, A., Schammann, T., Dill, P., Grunebach, F., Buhring, H.J., Kanz, L. and Brossart, P. (2001) "Dendritic cell-based vaccines in patients with hematological malignancies", Ann. N.Y. Acad. Sci. 938, 359-363.
69. Galea-Lauri, J., Darling, D., Mufti, G., Harrison, P. and Farzaneh, F. (2002) "Eliciting cytotoxic T lymphocytes against acute myeloid leukaemia-derived antigens: evaluation of dendritic cell-leukaemia cell hybrids and other antigen-loading strategies for dendritic cell-based vaccination", Cancer Immunol. Immunother. 51, 299-310.
70. Spisek, R., Chevallier, P., Morineau, N., Milpied, N., Avet-Loiseau, H., Harousseau, J.L., Meflah, K. and Gregoire, M. (2002) "Induction of leukaemic-specific cytotoxic response by cross-presentation of late-apoptotic leukemic blasts by autologous dendritic cells of nonleukemic origin", Cancer Res. 62, 2861-2868.
71. Rigolin, G.M., Howard, J., Buggins, A., Sneddon, C., Castoldi, G., Hirst, W.J.R. and Mufti, G.J. (1999) "Phenotypic and functional characteristics of monocyte-derived dendritic cells from patients with myelodysplastic syndromes", Br. J. Haematol. 107, 844-850.
72. Osman, Y., Takahashi, M., Zheng, Z., Toba, K., Liu, A., Furukawa, T., Narita, M., Aizawa, Y., Kokike, T. and Shibata, A. (1999) "Dendritic cells stimulate the expansion of PML-RAR alpha specific cytotoxic T-lymphocytes: its applicability for antileukemia immunotherapy", J. Exp. Clin. Cancer Res. 18, 485-492.
73. Ohminami, H., Yasukawa, M. and Fujita, S. (2000) "HLA class I-restricted lysis of leukemia cells by a CD8(+) cytotoxic T-lymphocyte clone specific for WT1 peptide", Blood 95, 286-293.
74. Knights, A.J., Zaniou, A., Rees, R.C., Pawelec, G. and Muller (2002) "Prediction of an HLA-DR-binding peptide from Wilms' tumour 1 protein and demonstration of in vitro immunogenicity of WT1 (124-138)-pulsed dendritic cells generated according to an optimised protocol", Cancer Immunol. Immunother. 51, 271-281.
75. Montagna, D., Maccario, R., Locatelli, F., Rosti, V., Yang, Y., Farness, P., Moretta, A., Comoli, P., Montini, E. and Vitiello, A. (2001) "Ex vivo priming for long term maintenance of antileukemia human cytotoxic T cells suggests a general procedure for adoptive immunotherapy", Blood 98, 3359-3366.
76. Fujii, S., Shimizu, K., Fujimoto, K., Kiyokawa, T., Tsukamoto, A., Sanada, I. and Kawano, F. (2001) "Treatment of post-transplanted, relapsed patients with hematological malignancies by infusion of HLA-matched, allogeneic-dendritic cells (DCs) pulsed with irradiated tumor cells and primed T cells", Leuk. Lymphoma 42, 357-369.
77. Krackhardt, A.M., Harig, S., Witzens, M., Broderick, R., Barrett, P. and Gribben, J.G. (2002) "T-cell responses against chronic lymphocytic leukaemia cells: implications for immunotherapy", Blood 100, 167-173.
78. Gong, J., Chen, D., Kashiwaba, M. and Kufe, D. (1997) "Induction of antitumour activity by immunisation with fusions of dendritic and carcinoma cells", Nat. Med. 3, 558-561.
79. Gong, J., Chen, D., Kashiwaba, M., Li, Y., Chen, L., Takeuchi, H., Qu, H., Rowse, G.J., Gender, S.J. and Kufe, D. (1998) "Reversal of tolerance to human MUC1 antigen in MUC1 transgenic mice immunised with fusions of dendritic and carcinoma cells", Proc. Natl Acad. Sci. USA 95, 6279-6283.
80. Gong, J., Nikrui, N., Chen, D., Koido, S., Wu, Z., Tanaka, Y., Cannistra, S., Avignan, D. and Kufe, D. (2000) "Fusions of human ovarian carcinoma cells with autologous or allogeneic DCs induce antitumour immunity", J. Immunol. 165, 1705-1711.
81. Kikuchi, T., Akasaki, Y., Irie, M., Homma, S., Abe, T. and Ohno, T. (2001) "Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells", Cancer Immunol. Immunother. 50, 337-344.
82. Kugler, A., Stuhler, G., Walden, P., Zoller, G., Zobywalski, A., Brossart, P., Trefzer, U., Ullrich, S., Muller, C.A., Becker, V., Gross, A.J., Hemmerlein, B., Kanz, L., Muller, G.A. and Ringert, R.H. (2000) "Regression of human metastatic renal cell carcinoma after vaccination with tumour cell-dendritic cell hybrids", Nat. Med. 6, 332-336.
83. Hersey, P. (1999) "Impediments to successful immunotherapy", Pharmacol. Ther. 81, 111-119.
84. Jonuleit, H., Schmitt, E., Steinbrink, K. and Enk, A.H. (2001) "Dendritic cells as a tool to induce anergic and regulatory T cells", Trends Immunol. 22, 394-400.
85. Gabrilovich, D.I., Chen, H.L., Girgis, K.R., Cunningham, H.T., Meny, G.M., Nadaf, S., Kavanaugh, D. and Carbone, D.P. (1996) "Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells", Nat. Med. 2, 1096-2003.
86. De Visser, K.E. and Kast, W.M. (1999) "Effects of TGF-β on the immune system: implications for cancer immunotherapy", Leukemia 13, 1188-1199.
87. Bright, J.J., Kerr, L.D. and Sriram, S. (1997) "TFG-β inhibits IL-2 induced tyrosine phosphorylation and activation of JAK-1 and STAT 5 in T lymphocytes", J. Immunol. 159, 175-183.
88. Cook, G., Campbell, J.D., Boyd, K.S., Carr, C.E. and Franklin, I.M. (1999) "Transforming growth factor β (TGF-β) from multiple myeloma cells inhibits proliferation and IL-2 responsiveness in T lymphocytes", J. Leukoc. Biol. 66, 981-988.
89. Campbell, J.D., Cook, G., Robertson, S.E., Fraser, A., Boyd, K.S., Gracie, J.A. and Franklin, I.M. (2001) "Suppression of IL-2-induced T cell proliferation and phosphorylation of STAT3 and STAT5 by tumour-derived TGF beta is reversed by IL-15", J. Immunol. 167, 553-561.
90. Brown, R.D., Pope, B., Muray, A., Esdale, W., Sze, D.M., Gibson, J., Ho, P.J., Hart, D. and Joshua, D. (2001) "Dendritic cells from patients with myeloma are numerically normal but functionally defective as they fail to upregulate CD80 (B7-1) expression after huCD50LT stimulation because of inhibition by transforming growth factor-beta 1 and interleukin-10", Blood 98, 2992-2998.
91. Steinbrink, K., Jonuleit, H., Muller, G., Schuler, G., Knop, J. and Enk, A.H. (1999) "Interleukin-10-treated dendritic cells induced a melanoma-antigen-specific anergy in CD8+ T cells resulting in a failure to lyse tumour cells", Blood 93, 1634-1642.
92. Chakraborty, A., Li, L., Chakraborty, N.G. and Mukherji, B. (2000) "Stimulatory and inhibitory differentiation of human myeloid dendritic cells", Clin. Immunol. 94, 88-98.
93. Ratta, M., Fagnoni, F., Curti, A., Vescovini, R., Sansoni, P., Oliviero, B., Fogli, M., Ferri, E., Della Cuna, G.R., Tura, S., Baccarani, M. and Lemoli, R.M. (2002) "Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6", Blood 100, 230-237.
94. Hilkens, C.M.U., Kalinski, P., de Boer, M. and Kapsenberg, M.L. (1997) "Human dendritic cells require exogenous Interleukin-12-inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype", Blood 90, 1920-1926.
95. Grohmann, U., Fioretti, M.C., Bianchi, R., Belladonna, M.L., Ayroldi, E., Surace, D., Silla, S. and Puccetti, P. (1998) "Dendritic cells, interleukin 12, and CD4+ lymphocytes in the initiation of class-I-restricted reactivity to a tumor/self peptide", Crit. Rev. Immunol. 18, 87-98.
96. Nagayama, H., Sato, K., Kawasaki, H., Enomoto, M., Morimoto, C., Tadokoro, K., Juji, T., Asano, S. and Takahashi, T.A. (2000) "IL-12 responsiveness and expression of IL-12 receptor in human peripheral blood monocyte derived dendritic cells", J. Immunol. 165, 59-66.
97. Gong, J., Koido, S., Chen, D., Tanaka, Y., Huang, L., Avignan, D., Anderson, K., Ohno, T. and Kufe, D. (2002) "Immunization against murine multiple myeloma with fusions of dendritic and plasmacytoma cells is potentiated by interleukin 12", Blood 99, 2512-2517.
98. Scrivener, S., Kaminski, E.R., Demaine, A. and Prentice, A.G. (2001) "Analysis of the expression of critical activation/interaction markers on peripheral blood T cells in B-cell chronic lymphocytic leukaemia: evidence of immune dysregulation", Br. J. Haematol. 112, 959-964.
99. Roskrow, M.A., Dilloo, D., Suzuki, N., Zhong, W., Rooney, C.M. and Brenner, M.K. (1999) "Autoimmune disease induced by dendritic cell immunization against leukemia", Leuk. Res. 23, 549-557.
100. Ludewig, B., Ochsenbein, A.F., Odermatt, B., Paulin, D., Hengartner, H. and Zinkernagel, R.M. (2000) "Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease", J. Exp. Med. 191,